A study of the natural history of diabetic kidney disease (DKD).

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 22058177)

Published in Nephrol Dial Transplant on November 05, 2011

Authors

Nagi Altemtam1, Jean Russell, Meguid El Nahas

Author Affiliations

1: Academic Nephrology Unit, Sheffield Kidney Institute, University of Sheffield, Sheffield, UK. naji_nw@yahoo.com

Articles citing this

Left ventricular assist devices: a kidney's perspective. Heart Fail Rev (2015) 1.99

Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant (2013) 1.55

Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS One (2012) 1.37

Uric acid as a target of therapy in CKD. Am J Kidney Dis (2012) 1.22

Fructose and uric acid in diabetic nephropathy. Diabetologia (2015) 0.99

Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial. PLoS One (2015) 0.96

Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol (2015) 0.94

Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan. Perit Dial Int (2013) 0.93

Long-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study. BMJ Open (2013) 0.89

Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma. Int J Clin Exp Pathol (2014) 0.88

Effects of proactive population-based nephrologist oversight on progression of chronic kidney disease: a retrospective control analysis. BMC Health Serv Res (2012) 0.82

Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population. PLoS One (2015) 0.80

Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig (2016) 0.79

Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease. Clin Exp Nephrol (2014) 0.78

Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review. PLoS One (2017) 0.77

Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression. Nephron Extra (2012) 0.77

Use of Contrast-Enhanced Ultrasound to Study Relationship between Serum Uric Acid and Renal Microvascular Perfusion in Diabetic Kidney Disease. Biomed Res Int (2015) 0.76

Single, community-based blood glucose readings may be a viable alternative for community surveillance of HbA1c and poor glycaemic control in people with known diabetes in resource-poor settings. Glob Health Action (2016) 0.75

Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials. Diabetes Obes Metab (2016) 0.75

Stop chronic kidney disease progression: Time is approaching. World J Nephrol (2016) 0.75

Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease. Clin Exp Nephrol (2015) 0.75

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial. J Adv Res (2017) 0.75

Mendelian randomization analysis indicates serum urate has a causal effect on renal function in Chinese women. Int Urol Nephrol (2017) 0.75

Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years. J Am Heart Assoc (2017) 0.75

Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes. Sci Rep (2017) 0.75

Articles by these authors

Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25

The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis (2005) 2.57

Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes (2002) 2.12

Do 'food deserts' influence fruit and vegetable consumption?--A cross-sectional study. Appetite (2005) 1.86

CKD and poverty: a growing global challenge. Am J Kidney Dis (2009) 1.62

OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant (2011) 1.44

'I'm pickin' up good regressions': the governance of generalisability analyses. Med Educ (2007) 1.24

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16

Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol (2011) 1.13

Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2007) 1.10

Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol (2008) 1.09

Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant (2009) 1.03

Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study). Cancer Epidemiol Biomarkers Prev (2007) 1.01

Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol (2007) 1.00

Chronic kidney disease in older people: physiology, pathology or both? Nephron Clin Pract (2010) 0.96

Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant (2007) 0.96

Effect of the foot on the mechanical alignment of the lower limbs. Clin Orthop Relat Res (2003) 0.95

Establishment of a European Network for Urine and Kidney Proteomics. J Proteomics (2008) 0.89

A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS). Am J Kidney Dis (2008) 0.89

Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring. Matrix Biol (2008) 0.85

School lunch menus and 11 to 12 year old children's food choice in three secondary schools in England-are the nutritional standards being met? Appetite (2005) 0.85

Meeting school food standards - students' food choice and free school meals. Public Health Nutr (2013) 0.84

Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt. Saudi J Kidney Dis Transpl (2011) 0.83

Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy. Nephron Clin Pract (2012) 0.83

Does breakfast-club attendance affect schoolchildren's nutrient intake? A study of dietary intake at three schools. Br J Nutr (2003) 0.82

Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. Proteomics Clin Appl (2011) 0.82

Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? Nephrol Dial Transplant (2012) 0.81

Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data. Nephrol Dial Transplant (2013) 0.81

Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease. Semin Nephrol (2009) 0.81

The Kidney Evaluation and Awareness Program in Sheffield (KEAPS): a community-based screening for microalbuminuria in a British population. Nephron Clin Pract (2010) 0.79

A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status. J Nutr (2012) 0.78

OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol (2008) 0.78

Proteinuria thresholds are irrational: a call for proteinuria indexing. Nephron Clin Pract (2010) 0.78

The epidemic challenge of chronic kidney disease in older patients. Postgrad Med (2008) 0.77

Effect of a tart cherry juice supplement on arterial stiffness and inflammation in healthy adults: a randomised controlled trial. Plant Foods Hum Nutr (2014) 0.77

Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. Nephron Clin Pract (2010) 0.76

Chronic kidney disease in Taiwan. Lancet (2008) 0.75

Twins and CKD: confounding nature's experiments! Nephrol Dial Transplant (2011) 0.75

Urinary albumin to protein ratio: more of the same or making a difference? Nephrol Dial Transplant (2012) 0.75

Screening strategies for CKD. Nephrol Dial Transplant (2010) 0.75

Characterisation of an in vitro system to study maternal communication with spermatozoa. Reprod Fertil Dev (2012) 0.75

New evidence of cardiac dysfunction associated with renal impairment. Int J Cardiol (2011) 0.75

Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response. Nephron Clin Pract (2011) 0.75

Introducing 'nephron clinical guidelines'. Nephron Clin Pract (2008) 0.75

Renal remodelling: complex interactions between renal and extra-renal cells. Pediatr Nephrol (2006) 0.75